CPX-351 is a drug that combines cytarabine and daunorubicin, and is approved for the treatment of acute myeloma leukemia. It is currently being studied for use in several other cancers.
| SparkCures ID | 547 |
|---|---|
| Brand Name | Vyxeos® |
| Generic Name | CPX-351 |
| Treatment Classifications |
There are no resources, links or videos to display for this treatment.